PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyJoanne I. Hsu, Margaret A. Goodell, Timothy P. Heffernan et al.|Cell stem cell|2018Cited by 423
Nearly a Third of Clonal Hematopoiesis-Associated DNMT3A Mutations Reduce Protein Stability and May be Associated with Poorer PrognosisYung‐Hsin Huang, Margaret A. Goodell, Alexander Meissner et al.|Blood|2018Cited by 2
<i>SOD1</i> is a synthetic lethal target in <i>PPM1D</i> -mutant leukemia cellsLinda Zhang, Margaret A. Goodell, Sarah M. Waldvogel et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 2
Clonal Competition: Cisplatin Treatment Drives Dominance of TP53- over Tet2-Mutant Stem Cell ClonesKatharina Wohlan, Margaret A. Goodell, Sarah Waldvogel et al.|Blood|2022Cited by 1
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cellsLinda Zhang, Margaret A. Goodell, Sarah M. Waldvogel et al.|eLife|2023Cited by 1